Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease

Diagnostic Microbiology and Infectious Disease

Volumn 92, Issue 3, 2018, Pages 210-213

  Hong, David K ^a   Blauwkamp, Timothy A ^a   Kertesz, Mickey ^a   Bercovici, Sivan ^a   Truong, Cynthia ^b   Banaei, Niaz ^b,c  

^a Karius Inc   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diagnostic biopsy; Invasive fungal infection; Molecular diagnostics; Next generation sequencing; Noninvasive

Indexed keywords

FUNGAL DNA; CELL FREE NUCLEIC ACID;

ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CELL FREE SYSTEM; CONTROLLED STUDY; CUNNINGHAMELLA; DNA DETERMINATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; HUMAN TISSUE; LIQUID BIOPSY; NEXT GENERATION SEQUENCING; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS; SCEDOSPORIUM; SEQUENCE HOMOLOGY; SYSTEMIC MYCOSIS; ADULT; AGED; BLOOD; COMMUNICABLE DISEASE; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES; YOUNG ADULT;

ADULT; AGED; CELL-FREE NUCLEIC ACIDS; COMMUNICABLE DISEASES; DNA, FUNGAL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INVASIVE FUNGAL INFECTIONS; LIQUID BIOPSY; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; YOUNG ADULT;

EID: 85049851763     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2018.06.009     Document Type: Article

References (26)

1. Abril, M.K., Barnett, A.S., Wegermann, K., Fountain, E., Strand, A., Heyman, B.M., et al. Diagnosis of Capnocytophaga canimorsus sepsis by whole-genome next-generation sequencing. Open Forum Infect Dis, 3(3), 2016.
2. Balajee, S.A., Gribskov, J.L., Hanley, E., Nickle, D., Marr, K.A., Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 4:3 (2005), 625–632.
3. De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:12 (2008), 1813–1821.
4. De Vlaminck, I., Khush, K.K., Strehl, C., Kohli, B., Luikart, H., Neff, N.F., et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell 155:5 (2013), 1178–1187.
5. De Vlaminck, I., Martin, L., Kertesz, M., Patel, K., Kowarsky, M., Strehl, C., et al. Noninvasive monitoring of infection and rejection after lung transplantation. Proc Natl Acad Sci U S A 112:43 (2015), 13336–13341.
6. Diehl, F., Schmidt, K., Choti, M.A., Romans, K., Goodman, S., Li, M., et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 14:9 (2008), 985–990.
7. Douglas, A.P., Chen, S.C., Slavin, M.A., Emerging infections caused by non-Aspergillus filamentous fungi. Clin Microbiol Infect 22:8 (2016), 670–680.
8. Fan, H.C., Blumenfeld, Y.J., Chitkara, U., Hudgins, L., Quake, S.R., Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105:42 (2008), 16266–16271.
9. Fishman, J.A., Infection in solid-organ transplant recipients. N Engl J Med 357:25 (2007), 2601–2614.
10. Gomez, C.A., Budvytiene, I., Zemek, A.J., Banaei, N., Performance of targeted fungal sequencing for culture-independent diagnosis of invasive fungal disease. Clin Infect Dis 65:12 (2017), 2035–2041.
11. Imbert, S., Gauthier, L., Joly, I., Brossas, J.Y., Uzunov, M., Touafek, F., et al. Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients. Clin Microbiol Infect, 22(6), 2016, 562 e1-8.
12. Ito, J.I., Kriengkauykiat, J., Dadwal, S.S., Arfons, L.M., Lazarus, H.M., Approaches to the early treatment of invasive fungal infection. Leuk Lymphoma 51:9 (2010), 1623–1631.
13. Labugger, I., Heyckendorf, J., Dees, S., Häussinger, E., Herzmann, C., Kohl, T.A., et al. Detection of transrenal DNA for the diagnosis of pulmonary tuberculosis and treatment. Infection 45:3 (2017), 269–276.
14. Lamoth, F., Cruciani, M., Mengoli, C., Castagnola, E., Lortholary, O., Richardson, M., et al. Beta-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 54:5 (2012), 633–643.
15. Mandel, P., Metais, P., Not Available. C R Seances Soc Biol Fil 142:3–4 (1948), 241–243.
16. Marr, K.A., Balajee, S.A., McLaughlin, L., Tabouret, M., Bentsen, C., Walsh, T.J., Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190:3 (2004), 641–649.
17. Menzin, J., Meyers, J.L., Friedman, M., Perfect, J.R., Langston, A.A., Danna, R.P., et al. Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm 66:19 (2009), 1711–1717.
18. Pagano, L., Caira, M., Valentini, C.G., Posteraro, B., Fianchi, L., Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Blood Rev 24:2 (2010), 51–61.
19. Patterson, T.F., Thompson, G.R. III, Denning, D.W., Fishman, J.A., Hadley, S., Herbrecht, R., et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:4 (2016), e1–e60.
20. Perlin, D.S., Rautemaa-Richardson, R., Alastruey-Izquierdo, A., The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:12 (2017), e383–e392.
21. Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T.J., Kontoyiannis, D.P., Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54:Suppl. 1 (2012), S23–S34.
22. Pizzo, P.A., Robichaud, K.J., Gill, F.A., Witebsky, F.G., Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 72:1 (1982), 101–111.
23. Salzberg, S.L., Breitwieser, F.P., Kumar, A., Hao, H., Burger, P., Rodriguez, F.J., et al. Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system. Neurol Neuroimmunol Neuroinflamm, 3(4), 2016, e251.
24. Snyder, T.M., Khush, K.K., Valantine, H.A., Quake, S.R., Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci U S A 108:15 (2011), 6229–6234.
25. Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15:10 (2009), 1143–1238.
26. Wilson, M.R., Naccache, S.N., Samayoa, E., Biagtan, M., Bashir, H., Yu, G., et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 370:25 (2014), 2408–2417.